Nivedita Gupta

SARS-CoV-2 Spike Mutations, L452R, T478K, E484Q and P681R, in the Second Wave of COVID-19 in Maharashtra, India

Sarah Cherian, Varsha Potdar, Santosh Jadhav et al. · Microorganisms · 2021 · 658 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +15

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: a double-blind, randomised, phase 1 trial

Raches Ella, Krishna Mohan Vadrevu, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 438 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBV152: interim results from a double-blind, randomised, multicentre, phase 2 trial, and 3-month follow-up of a double-blind, randomised phase 1 trial

Raches Ella, Siddharth Reddy, Harsh Jogdand et al. · The Lancet Infectious Diseases · 2021 · 365 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial

Raches Ella, Siddarth Reddy, William C. Blackwelder et al. · The Lancet · 2021 · 362 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Convergent evolution of SARS-CoV-2 spike mutations, L452R, E484Q and P681R, in the second wave of COVID-19 in Maharashtra, India

Sarah Cherian, Varsha Potdar, Santosh Jadhav et al. · bioRxiv (Cold Spring Harbor Laboratory) · 2021 · 268 citations · Full text

Life Sciences, Infectious Diseases, Molecular Genetics +17